Magaldrate
From Wikipedia, the free encyclopedia
Magaldrate
|
|
Systematic (IUPAC) name | |
Magnesium aluminate monohydrate | |
Identifiers | |
CAS number | |
ATC code | A02 A02AF01 |
PubChem | |
Chemical data | |
Formula | ? |
Mol. mass | 86.3092 g/mol |
Pharmacokinetic data | |
Bioavailability | Negligible |
Metabolism | Nil |
Half life | ? |
Excretion | Fecal and renal |
Therapeutic considerations | |
Pregnancy cat. |
C |
Legal status |
OTC |
Routes | Oral |
Magaldrate (INN), is a common antiacid drug that is used for the treatment of duodenal and gastric ulcers, esophagitis from gastroesophageal reflux.
Contents |
[edit] Formula
Al5Mg10(OH)31(SO4)2 H2O
[edit] Available forms
Magaldrate is available in the form of oral suspension or tablets.
[edit] Interactions and adverse reactions
Magaldrate may negatively influence drugs like tetracyclines, benzodiazepines, and indomethacin. High doses or prolonged usage may lead to an increment of defecation and a reduction in feces consistance. In some cases it can alter the functionality of the gastrointestinal tract, occasionally provoking constipation or diarrhea.
[edit] Brand names
The drug is sold with the following brand names:
- Gradal® (Italy);
- Magaltop® (Italy);
- Magralibi® (Italy);
- Riopan® (Argentina, Austria, Brazil, Germany, Italy).